Guided Therapeutics (GTHP) Gains from Investment Securities (2016 - 2025)

Guided Therapeutics' Gains from Investment Securities history spans 14 years, with the latest figure at $12000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 71.43% to $12000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $65000.0, a 10.17% increase, with the full-year FY2025 number at $33000.0, down 98.86% from a year prior.
  • Gains from Investment Securities hit $12000.0 in Q4 2025 for Guided Therapeutics, down from $2.8 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for GTHP hit a ceiling of $3.1 million in Q2 2025 and a floor of -$151000.0 in Q2 2022.
  • Historically, Gains from Investment Securities has averaged $979296.6 across 5 years, with a median of $40000.0 in 2021.
  • Biggest five-year swings in Gains from Investment Securities: crashed 15200.0% in 2022 and later surged 102400.0% in 2023.
  • Tracing GTHP's Gains from Investment Securities over 5 years: stood at $34000.0 in 2021, then skyrocketed by 864.71% to $328000.0 in 2022, then plummeted by 85.98% to $46000.0 in 2023, then crashed by 84.78% to $7000.0 in 2024, then surged by 71.43% to $12000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for GTHP at $12000.0 in Q4 2025, $2.8 million in Q3 2025, and $3.1 million in Q2 2025.